pubmed-article:2918589 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:2918589 | lifeskim:mentions | umls-concept:C0242350 | lld:lifeskim |
pubmed-article:2918589 | lifeskim:mentions | umls-concept:C0030350 | lld:lifeskim |
pubmed-article:2918589 | lifeskim:mentions | umls-concept:C0030847 | lld:lifeskim |
pubmed-article:2918589 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:2918589 | lifeskim:mentions | umls-concept:C0002335 | lld:lifeskim |
pubmed-article:2918589 | lifeskim:mentions | umls-concept:C0031448 | lld:lifeskim |
pubmed-article:2918589 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
pubmed-article:2918589 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:2918589 | pubmed:dateCreated | 1989-3-30 | lld:pubmed |
pubmed-article:2918589 | pubmed:abstractText | The use of intracavernous prostaglandin E1 was studied in 48 organically impotent men. Eight men with previous chemical priapism did not have chemically induced priapism at up to 4 times the minimum effective dose of prostaglandin E1. Of 15 men with arteriogenic impotence who had failed prior intracavernous phentolamine and papaverine therapy 10 had adequate erections with prostaglandin E1. A total of 25 men received intracavernous prostaglandin E1 and phentolamine plus papaverine in a double-blind fashion. Erections with prostaglandin E1 were equal or superior to those with phentolamine plus papaverine in each case. | lld:pubmed |
pubmed-article:2918589 | pubmed:language | eng | lld:pubmed |
pubmed-article:2918589 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2918589 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:2918589 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2918589 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2918589 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2918589 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:2918589 | pubmed:month | Mar | lld:pubmed |
pubmed-article:2918589 | pubmed:issn | 0022-5347 | lld:pubmed |
pubmed-article:2918589 | pubmed:author | pubmed-author:SzaszGG | lld:pubmed |
pubmed-article:2918589 | pubmed:author | pubmed-author:LeeL MLM | lld:pubmed |
pubmed-article:2918589 | pubmed:author | pubmed-author:StevensonR... | lld:pubmed |
pubmed-article:2918589 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:2918589 | pubmed:volume | 141 | lld:pubmed |
pubmed-article:2918589 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:2918589 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:2918589 | pubmed:pagination | 549-50 | lld:pubmed |
pubmed-article:2918589 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
pubmed-article:2918589 | pubmed:meshHeading | pubmed-meshheading:2918589-... | lld:pubmed |
pubmed-article:2918589 | pubmed:meshHeading | pubmed-meshheading:2918589-... | lld:pubmed |
pubmed-article:2918589 | pubmed:meshHeading | pubmed-meshheading:2918589-... | lld:pubmed |
pubmed-article:2918589 | pubmed:meshHeading | pubmed-meshheading:2918589-... | lld:pubmed |
pubmed-article:2918589 | pubmed:meshHeading | pubmed-meshheading:2918589-... | lld:pubmed |
pubmed-article:2918589 | pubmed:meshHeading | pubmed-meshheading:2918589-... | lld:pubmed |
pubmed-article:2918589 | pubmed:meshHeading | pubmed-meshheading:2918589-... | lld:pubmed |
pubmed-article:2918589 | pubmed:meshHeading | pubmed-meshheading:2918589-... | lld:pubmed |
pubmed-article:2918589 | pubmed:meshHeading | pubmed-meshheading:2918589-... | lld:pubmed |
pubmed-article:2918589 | pubmed:year | 1989 | lld:pubmed |
pubmed-article:2918589 | pubmed:articleTitle | Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison. | lld:pubmed |
pubmed-article:2918589 | pubmed:affiliation | Department of Surgery, University of British Columbia, Vancouver, Canada. | lld:pubmed |
pubmed-article:2918589 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:2918589 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:2918589 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:2918589 | pubmed:publicationType | Controlled Clinical Trial | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2918589 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2918589 | lld:pubmed |